CXCL5 and viral infectious disease: Collectively, these results suggest that although a lack of CXCL5 alleviates lung inflammation during the early stage and affects viral clearance to some extent during the late stage of influenza virus infection in mice, it does not obviously improve the overall outcome of viral infection in terms of survival rate, viral clearance time, lung inflammation development or establishment of adaptive immunity.